BIOMARIN PHARMACEUTICAL INC - Common Stock (BMRN)
CUSIP: 09061G101
Q2 2014 13F Holders as of 30 Jun 2014
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 192,975,286
- Total 13F shares
- 144,555,723
- Share change
- -3,950,657
- Total reported value
- $8,993,046,726
- Put/Call ratio
- 76%
- Price per share
- $62.21
- Number of holders
- 319
- Value change
- -$244,244,682
- Number of buys
- 162
- Number of sells
- 139
Quarterly Holders Quick Answers
What is CUSIP 09061G101?
CUSIP 09061G101 identifies BMRN - BIOMARIN PHARMACEUTICAL INC - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 09061G101:
Top shareholders of BMRN - BIOMARIN PHARMACEUTICAL INC - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Capital Research Global Investors |
13F
|
Company |
9.2%
|
17,777,593
|
$1,212,610,000 | — | 31 Mar 2014 | |
| SANDS CAPITAL MANAGEMENT, LLC |
13F
|
Company |
5%
|
9,737,665
|
$664,206,000 | — | 31 Mar 2014 | |
| PRIMECAP MANAGEMENT CO/CA/ |
13F
|
Company |
4.2%
|
8,163,719
|
$556,847,000 | — | 31 Mar 2014 | |
| VANGUARD GROUP INC |
13F
|
Company |
4.2%
|
8,031,118
|
$547,803,000 | — | 31 Mar 2014 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
4.2%
|
8,019,752
|
$547,027,000 | — | 31 Mar 2014 | |
| FMR LLC |
13F
|
Company |
3.8%
|
7,298,651
|
$497,841,000 | — | 31 Mar 2014 | |
| Winslow Capital Management, LLC |
13F
|
Company |
2.5%
|
4,821,013
|
$328,841,000 | — | 31 Mar 2014 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
1.5%
|
2,941,687
|
$302,246,684 | — | 31 Mar 2014 | |
| STATE STREET CORP |
13F
|
Company |
2%
|
3,891,758
|
$265,453,000 | — | 31 Mar 2014 | |
| BlackRock Institutional Trust Company, N.A. |
13F
|
Company |
1.8%
|
3,474,999
|
$237,030,000 | — | 31 Mar 2014 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
1.8%
|
3,467,745
|
$236,505,000 | — | 31 Mar 2014 | |
| BlackRock Fund Advisors |
13F
|
Company |
1.5%
|
2,844,159
|
$194,000,000 | — | 31 Mar 2014 | |
| BLAIR WILLIAM & CO/IL |
13F
|
Company |
1.2%
|
2,411,713
|
$164,503,000 | — | 31 Mar 2014 | |
| TCW GROUP INC |
13F
|
Company |
1.2%
|
2,365,241
|
$161,333,000 | — | 31 Mar 2014 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.2%
|
2,299,949
|
$156,880,000 | — | 31 Mar 2014 | |
| Blue Ridge Capital, L.L.C. |
13F
|
Company |
1.1%
|
2,060,000
|
$140,513,000 | — | 31 Mar 2014 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.98%
|
1,883,230
|
$128,455,000 | — | 31 Mar 2014 | |
| ALTRINSIC GLOBAL ADVISORS LLC |
13F
|
Company |
0.95%
|
1,828,578
|
$124,727,000 | — | 31 Mar 2014 | |
| Amici Capital, LLC |
13F
|
Company |
0.94%
|
1,805,362
|
$123,144,000 | — | 31 Mar 2014 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.89%
|
1,714,165
|
$116,923,000 | — | 31 Mar 2014 | |
| Neuberger Berman Group LLC |
13F
|
Company |
0.87%
|
1,678,000
|
$114,456,000 | — | 31 Mar 2014 | |
| HOLLAND CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.84%
|
1,622,724
|
$110,686,000 | — | 31 Mar 2014 | |
| MUNDER CAPITAL MANAGEMENT |
13F
|
Company |
0.83%
|
1,610,296
|
$109,839,000 | — | 31 Mar 2014 | |
| Temasek Holdings (Private) Ltd |
13F
|
Company |
0.8%
|
1,551,854
|
$105,852,000 | — | 31 Mar 2014 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.77%
|
1,493,000
|
$101,838,000 | — | 31 Mar 2014 | |
| ALKEON CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.75%
|
1,451,500
|
$99,007,000 | — | 31 Mar 2014 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.75%
|
1,450,568
|
$98,943,000 | — | 31 Mar 2014 | |
| COLUMBIA WANGER ASSET MANAGEMENT LLC |
13F
|
Company |
0.72%
|
1,389,000
|
$94,744,000 | — | 31 Mar 2014 | |
| MANAGED ACCOUNT ADVISORS LLC |
13F
|
Company |
0.69%
|
1,339,523
|
$91,368,000 | — | 31 Mar 2014 | |
| BlackRock Group LTD |
13F
|
Company |
0.66%
|
1,279,640
|
$87,285,000 | — | 31 Mar 2014 | |
| Invesco Ltd. |
13F
|
Company |
0.64%
|
1,235,969
|
$84,305,000 | — | 31 Mar 2014 | |
| BLACKROCK ADVISORS LLC |
13F
|
Company |
0.63%
|
1,214,548
|
$82,844,000 | — | 31 Mar 2014 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.61%
|
1,174,818
|
$80,135,000 | — | 31 Mar 2014 | |
| Capital World Investors |
13F
|
Company |
0.58%
|
1,120,000
|
$76,395,000 | — | 31 Mar 2014 | |
| NORGES BANK |
13F
|
Company |
0.58%
|
1,116,833
|
$76,179,000 | — | 31 Mar 2014 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.58%
|
1,111,893
|
$75,842,000 | — | 31 Mar 2014 | |
| GILDER GAGNON HOWE & CO LLC |
13F
|
Company |
0.57%
|
1,105,610
|
$75,414,000 | — | 31 Mar 2014 | |
| WADDELL & REED FINANCIAL INC |
13F
|
Company |
0.52%
|
1,005,813
|
$68,606,000 | — | 31 Mar 2014 | |
| SECTORAL ASSET MANAGEMENT INC |
13F
|
Company |
0.48%
|
927,406
|
$63,258,000 | — | 31 Mar 2014 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.48%
|
924,047
|
$63,029,000 | — | 31 Mar 2014 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.47%
|
911,283
|
$62,159,000 | — | 31 Mar 2014 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.47%
|
906,328
|
$61,819,000 | — | 31 Mar 2014 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.44%
|
841,559
|
$57,403,000 | — | 31 Mar 2014 | |
| Clearbridge Investments, LLC |
13F
|
Company |
0.4%
|
770,407
|
$52,549,000 | — | 31 Mar 2014 | |
| Palo Alto Investors LP |
13F
|
Company |
0.39%
|
745,687
|
$50,863,000 | — | 31 Mar 2014 | |
| USS Investment Management Ltd |
13F
|
Company |
0.38%
|
739,334
|
$50,430,000 | — | 31 Mar 2014 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.37%
|
721,242
|
$49,186,000 | — | 31 Mar 2014 | |
| COLUMBUS CIRCLE INVESTORS |
13F
|
Company |
0.33%
|
640,849
|
$43,712,000 | — | 31 Mar 2014 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.33%
|
637,546
|
$43,487,000 | — | 31 Mar 2014 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.31%
|
601,580
|
$41,033,000 | — | 31 Mar 2014 |
Institutional Holders of BIOMARIN PHARMACEUTICAL INC - Common Stock (BMRN) as of Q2 2014
As of 30 Jun 2014,
BIOMARIN PHARMACEUTICAL INC - Common Stock (BMRN) was held by
319 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
144,555,723 shares.
The largest 10 holders included
Capital Research Global Investors, SANDS CAPITAL MANAGEMENT, LLC, FMR LLC, VANGUARD GROUP INC, PRIMECAP MANAGEMENT CO/CA/, JENNISON ASSOCIATES LLC, State Street Corp, BlackRock Institutional Trust Company, N.A., WELLS FARGO & COMPANY/MN, and BlackRock Fund Advisors.
This page lists
319
institutional shareholders reporting positions in this security
for the Q2 2014 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2014 vs Q1 2014 Across Filers
Q1 2014 holders
309
Q2 2014 holders
319
Holder diff
10
| Investor | Q1 2014 Shares | Q2 2014 Shares | Share Diff | Share Chg % | Q1 2014 Value $ | Q2 2014 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.